BioCentury
PRESENTATION | Finance

4Q24 Wrap: They all fall down

Winners, losers in biotech stock tiers in 4Q24

January 17, 2025 1:16 AM UTC

Biotech stocks fell in 4Q24, undoing all of 3Q24’s gains to put all market cap tiers into the red for the full year. 

The largest companies, those starting with market caps above $10B, lost the least: a median of 10% for the quarter and 1% for the year. Ten companies gained value in the quarter while 25 declined...